-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Adolescents (12-17 years)
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Mpox
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Primary care
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Hydroxy gas
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Pharmacological intervention
-
Monoclonal antibodies
-
Temelimab
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Rehabilitation
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Acute COVID-19
-
Pharmacological intervention
-
Antivirals
-
Nirmatrelvir/Ritonavir
-
Molnupiravir
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Pharmacological intervention
-
Corticosteroid
-
Methylprednisolone
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Post COVID-19 condition
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
SARS-CoV-2
-
Post COVID-19 condition
-
Non pharmacological intervention
-
Immunoadsorption
-
Adults (18-64 years)
-
Elderly (≥65 years)
-
Fragile population
-
Immunocompromised host
-
Hospital
-
Outpatient clinic
-
SARS-CoV-2
-
Acute COVID-19
-
Adults (18-64 years)
-
General population
-
Elderly (≥65 years)
-
Hospital
-
Outpatient clinic
-
Monkeypox virus
-
Mpox